Sandra N. Milik

Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors

Sandra N. Milik, Amal Kamal Abdel‐Aziz, Deena S. Lasheen et al. · European Journal of Medicinal Chemistry · 2018 · 68 citations · Full text

Medicinal Chemistry, Medicine, Rational Drug Design +9

Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria

Eman M.E. Dokla, Nader S. Abutaleb, Sandra N. Milik et al. · European Journal of Medicinal Chemistry · 2019 · 68 citations

Synergistic Effect, Benzimidazole-based Derivatives, Antibiotics +10

SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria

Eman M.E. Dokla, Nader S. Abutaleb, Sandra N. Milik et al. · European Journal of Medicinal Chemistry · 2022 · 23 citations

Benzimidazole-based Derivatives, Antibiotics, Medicine +11

Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia

Eman M.E. Dokla, Amal Kamal Abdel‐Aziz, Sandra N. Milik et al. · Bioorganic & Medicinal Chemistry · 2021 · 20 citations · Full text

Hematological Malignancy, Oncology, Medicine +9

Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer

Eman M.E. Dokla, Amal Kamal Abdel‐Aziz, Sandra N. Milik et al. · Bioorganic Chemistry · 2021 · 19 citations

Medicinal Chemistry, Drug Targeting, Medicine +9